Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Immune therapy for cancer can cause hair loss scars in some patients.

Gut bacteria may influence hair loss in alopecia areata.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Quercetin effectively treated and prevented hair loss in mice.

Blocking LFA-1 prevents hair loss in mice.

Some treatments for multiple sclerosis can cause hair loss.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Bicalutamide may help treat female pattern hair loss.

Combining stress management and Minoxidil helps treat stress-related hair loss and improve well-being.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Similar treatments might work for different types of scarring hair loss.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Targeting inflammation can improve scalp and hair health.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Astressin-B can reverse and prevent hair loss in stressed mice.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.